Beijing, China

Ruijun Li


 

Average Co-Inventor Count = 14.6

ph-index = 1


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Ruijun Li: Innovator in Apoptosis Inhibition

Introduction

Ruijun Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly in the area of apoptosis inhibition. With a total of three patents to his name, his work focuses on developing compounds that can combat apoptosis and related diseases.

Latest Patents

Li's latest patents include innovative compounds aimed at inhibiting apoptosis. One of his notable inventions is related to acrylamide compounds, which are designed to prevent or treat diseases associated with apoptosis, particularly in cardiomyocytes. This invention includes a compound of Formula I, along with its isomers, pharmaceutically acceptable salts, and solvates. The composition is intended for use in combating apoptosis and protecting cardiomyocytes from related disorders.

Another significant patent involves urea compounds that also target apoptosis inhibition. Similar to his acrylamide compounds, this invention provides a composition containing a compound of Formula I, or its isomers, and is aimed at preventing or treating diseases associated with apoptosis, especially in cardiomyocytes.

Career Highlights

Ruijun Li is currently affiliated with the Chinese PLA General Hospital, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on treating diseases linked to apoptosis, making him a valuable asset in the medical research community.

Collaborations

Li collaborates with notable colleagues, including Song Li and Wu Zhong, who contribute to his research endeavors. Their combined expertise enhances the development of innovative solutions in the field of apoptosis inhibition.

Conclusion

Ruijun Li's contributions to the field of apoptosis inhibition through his innovative patents highlight his role as a leading inventor in medical research. His work has the potential to significantly impact the treatment of diseases associated with apoptosis, particularly in cardiomyocytes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…